Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Circulation Research
|
April 26, 2008
Living on the edge: hypoxia-induced tissue damage
Evren Caglayan, Stephan Rosenkranz
Medizinische Klinik (Munich, Germany : 1983)
|
August 19, 2007
[Novel indications for phosphodiesterase type 5 inhibitors]
Stephan Rosenkranz, Evren Caglayan, Erland Erdmann
Deutsche Medizinische Wochenschrift (1946)
|
May 21, 2008
[Detached point of a thin lumen thorax drainage tube in the right lung]
Fikret Er, Evren Caglayan, Erland Erdmann
Endocrinology and Metabolism Clinics of North America
|
September 9, 2006
Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes
Florian Blaschke, Evren Caglayan, Willa A Hsueh
Cardiology Research and Practice
|
March 28, 2013
Atrial fibrillation
Natig Gassanov, Evren Caglayan, Firat Duru, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac Remodeling
Piotr Kmieć, Stephan Rosenkranz, Margarete Odenthal, et al.
Current Opinion in Pharmacology
|
March 23, 2005
Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways
Evren Caglayan, Florian Blaschke, Yasunori Takata, et al.
Thescientificworldjournal
|
June 8, 2010
Atrial septal aneurysm: a major diagnostic clue for a patent foramen ovale
Amir M Nia, Natig Gassanov, Evren Caglayan, et al.
Journal of the American Society of Nephrology : JASN
|
December 7, 2013
Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option?
Natig Gassanov, Amir M Nia, Evren Caglayan, et al.
World Journal of Gastroenterology
|
November 18, 2014
Cirrhotic cardiomyopathy: a cardiologist's perspective
Natig Gassanov, Evren Caglayan, Nasser Semmo, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Circulation Research
|
April 26, 2008
Living on the edge: hypoxia-induced tissue damage
Evren Caglayan, Stephan Rosenkranz
Medizinische Klinik (Munich, Germany : 1983)
|
August 19, 2007
[Novel indications for phosphodiesterase type 5 inhibitors]
Stephan Rosenkranz, Evren Caglayan, Erland Erdmann
Deutsche Medizinische Wochenschrift (1946)
|
May 21, 2008
[Detached point of a thin lumen thorax drainage tube in the right lung]
Fikret Er, Evren Caglayan, Erland Erdmann
Endocrinology and Metabolism Clinics of North America
|
September 9, 2006
Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes
Florian Blaschke, Evren Caglayan, Willa A Hsueh
Cardiology Research and Practice
|
March 28, 2013
Atrial fibrillation
Natig Gassanov, Evren Caglayan, Firat Duru, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac Remodeling
Piotr Kmieć, Stephan Rosenkranz, Margarete Odenthal, et al.
Current Opinion in Pharmacology
|
March 23, 2005
Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways
Evren Caglayan, Florian Blaschke, Yasunori Takata, et al.
Thescientificworldjournal
|
June 8, 2010
Atrial septal aneurysm: a major diagnostic clue for a patent foramen ovale
Amir M Nia, Natig Gassanov, Evren Caglayan, et al.
Journal of the American Society of Nephrology : JASN
|
December 7, 2013
Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option?
Natig Gassanov, Amir M Nia, Evren Caglayan, et al.
World Journal of Gastroenterology
|
November 18, 2014
Cirrhotic cardiomyopathy: a cardiologist's perspective
Natig Gassanov, Evren Caglayan, Nasser Semmo, et al.
Page
of 6